You are here

Member Profile

Membership type: full

Paola Mariela Saba Villarroel

Country of origin: Bolivia Currently in: Thailand, Bangkok General field of specialization: Structural, Cell and Molecular Biology
Academic Background


2020 Doctorate Structural, Cell and Molecular Biology
2015 Master Structural, Cell and Molecular Biology
2011 Undergraduate Medical and Health Sciences incl Neurosciences
Research and Profession

Current Research Activities

Structural, Cell and Molecular Biology

Emerging viruses

Publications resulting from Research: 

Global seroprevalence of Zika virus in asymptomatic individuals: A systematic review.

PLOS Neglected Tropical Diseases. 17 Apr 2024

SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.

Sci. Reports, Feb 2024

Emerging and Re-emerging Zoonotic Viral Diseases in Southeast Asia: One Health Challenge.

Frontiers in Public Health, Jun 12 2023

SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021.

IScience, 21 Apr 2023

Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali.

Emerg Infect Dis, 28 Dec 2022

Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population.

Int. J. Environ. Res. Public Health, 18 Nov 2022

Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.

JAMA 09 Nov 2022

In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5.

Sci. Reports, 23 Jul 2022

Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.

Sci. Reports, 13 Jul 2022.

Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.

Sci. Reports, 21 May 2022

Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.

Viruses, 3 May 2022

Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France).

IJERPH, 10 Feb 2022

Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France.

Infection, Feb 2022

High SARS-CoV-2 Prevalence among Healthcare Workers in Cochabamba, Bolivia.

Viruses, 25 Jan 2022

Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia.

British Journal of Haematology, Jan 2022

Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°C.

Vector Borne Zoonotic Dis, 21 Dec 2021

A clinical, aetiological, and public health perspective on central nervous system infections in Bolivia, 2017–2018.

Sci. Reports, 01 Dec 2021.

Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy.

Multiple sclerosis journal - experimental, translational and clinical. 21 Nov 2021

Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia.

British Journal of Haematology. 01 Aug 2021

Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People.

Frontiers in Public Health, 26 Jul 2021

Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

International Journal of Epidemiology, 19 Jul 2021

Spike and neutralizing antibodies response to COVID-19 vaccination in hemodialysis patients.

Clinical Kidney Journal. 06 Jul 2021

Zika virus infection in pregnancy: A protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortia.

BMJ open, 15 Dec 2020

Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortium.

BMC infectious diseases, 26 Dec 2019

Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies.

Virology Journal, 27 Dec 2018.

Zika virus epidemiology in Bolivia: A seroprevalence study in volunteer blood donors.

PLoS Neglected Tropical Diseases, 07 Mar 2018.

First molecular survey on antimicrobial resistance markers in Enterobacteriaceae, in Cochabamba, Bolivia.

Revista Argentina de Microbiología, Mar 2017.

Current profession

Current professional activities type: 

Search form